Determine the necessary mass, volume, or concentration for preparing a solution.
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Taxonomy Tree
| Kingdom | Organic compounds |
|---|---|
| Superclass | Organoheterocyclic compounds |
| 分類 | Oxazaphosphinanes |
| Subclass | Isofamides |
| Intermediate Tree Nodes | Not available |
| Direct Parent | Isofamides |
| Alternative Parents | Phosphoric monoester diamides Oxacyclic compounds Azacyclic compounds Organopnictogen compounds Organooxygen compounds Organonitrogen compounds Organochlorides Organic oxides Hydrocarbon derivatives Alkyl chlorides |
| Molecular Framework | Aliphatic heteromonocyclic compounds |
| Substituents | Isofamide - Phosphoric monoester diamide - Organic phosphoric acid derivative - Organic phosphoric acid amide - Azacycle - Oxacycle - Alkyl chloride - Hydrocarbon derivative - Organic oxide - Organopnictogen compound - Organooxygen compound - Organonitrogen compound - Organochloride - Organic oxygen compound - Organohalogen compound - Organic nitrogen compound - Alkyl halide - Aliphatic heteromonocyclic compound |
| 説明 | This compound belongs to the class of organic compounds known as isofamides. These are oxazaphospholanes containing the isofamide skeleton. Isofamide is a heterocyclic compound made up of a 1,3,2-oxazaphospholane, where the phosphorus atom is part of a phosphodiamide group, and the oxazaphospholane is substituted by two haloalkyl chains. |
| External Descriptors | ifosfamides |
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Find and download the COA for your product by matching the lot number on the packaging.
| Lot Number | Certificate Type | 日付 | 商品 |
|---|---|---|---|
| Certificate of Analysis | Jul 17, 2023 | I123381 |
| 融点(°C) | 42 °C |
|---|---|
| 分子量 | 261.079 g/mol |
| XLogP3 | 0.900 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 5 |
| Exact Mass | 260.025 Da |
| Monoisotopic Mass | 260.025 Da |
| Topological Polar Surface Area | 41.600 Ų |
| Heavy Atom Count | 14 |
| Formal Charge | 0 |
| Complexity | 218.000 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| The total count of all stereochemical bonds | 0 |
| Covalently-Bonded Unit Count | 1 |
Specific, validated application protocols (e.g., WB, IHC, IF, FC) are not applicable to this small-molecule compound and are not provided in the Product Data. For general use in research:
Stock solution prep (general):
Aqueous working solutions:
Analytical calibration:
Always adapt to your institution’s cytotoxic handling SOPs and consult the lot-specific CoA/SDS.
Biochemical context (literature; no clinical claims): Ifosfamide is an oxazaphosphorine prodrug that requires metabolic activation to generate bifunctional electrophiles capable of DNA crosslinking.
Activation pathways (general literature):
Molecular interactions:
Research utilities:
Note: Exact biotransformation rates and species dependence vary; verify conditions with your biological system of interest.
Not a buffering agent. Ifosfamide does not function as an acid/base buffer. However, buffers are often used to dissolve and stabilize the compound in research assays.
Practical dissolution buffers (general guidance):
Tips:
Green chemistry considerations center on handling, solvent choice, and waste minimization rather than substituting the active compound.
Why substitution is not applicable:
Greener practice options (general):
Comparative solvent impact (general guidance):
Process improvements:
Context (no therapeutic claims): Ifosfamide is a well-known active pharmaceutical ingredient (API) in the oxazaphosphorine class. The information below focuses on formulation and analytical considerations relevant to research and development workflows.
Formulation considerations (general literature):
Reference/analytical uses in pharma R&D:
Compliance notes for this catalog item:
Pharmacopeial status: Consult current pharmacopeias for monograph details; not specified for this item.
Item-specific specifications are limited in the current Product Data. Values below are provided only as general literature guidance and are not specifications for this catalog item.
Item-specific (from Product Data):
Literature/general properties (not item specifications):
Practical notes (general):
Grade: Moligand™, Pharmaceutical grade (as listed in Product Data).
What this means for this item:
Typical controls and documentation (general, consult lot CoA):
Stabilizers/format:
Practical implications:
This compound is primarily a research reference/biological tool compound rather than a synthetic reagent.
Not typical as a solvent or general-purpose reagent; instead, it is used to:
Practical research tips:
If a chemical transformation is required (derivatization for analytics):
Note: For synthetic organic transformations or named-reaction chemistry, Ifosfamide is not commonly employed as a building block or reagent.
Not applicable as a general reagent. This product is not typically used to run synthetic transformations. However, the following general handling conditions support research workflows involving solution preparation and stability assessment.
Solution preparation (general guidance):
Analytical method conditions (literature examples, not specifications):
Expected behavior (general):
Note: No yield/kinetic data are specified for this item; consult primary literature for system-specific rates.
Caution: Ifosfamide is a cytotoxic alkylating agent. Apply containment and controls appropriate for antineoplastic/oncology compounds.
Item-specific (from Product Data):
Literature-based hazards (not item specifications; consult SDS for authoritative data):
Engineering controls and PPE (best practice):
Incompatibilities and stability (general):
First-aid overview (general guidance; defer to SDS):
Waste: Collect as hazardous cytotoxic waste; segregate and incinerate in accordance with institutional and local regulations.
Ifosfamide is a polar, neutral small molecule; dissolution strategy depends on assay needs and stability.
General miscibility profile (literature-informed):
Practical solvent choices:
Comparison notes:
Tip: Filter (0.2 µm PTFE or PVDF) only if needed; adsorption losses are generally low but can occur—validate recovery for quantitative work.
Item-specific storage (from Product Data):
Store at 2–8°C.
Shipped on wet ice.
Container and environment:
Reconstitution and solution stability (general guidance; not item specifications):
Stability notes:
Documentation:
Disposal:
Quick ID. Ifosfamide (CAS 3778-73-2) is a small-molecule oxazaphosphorine alkylating agent, supplied as part of Aladdin’s Moligand™ pharmaceutical-grade library for research use.
Item-specific (from Product Data):
Literature structural identifiers (for reference only; not item specifications):
Key structural features (general description):
2D structural description (words): A P(V)=O center is part of a five-membered O–C–N–C–P ring; the exocyclic P–N and/or ring N bear 2-chloroethyl arms, furnishing two β-chloro substituents capable of intramolecular activation and DNA crosslinking (biochemical context).
Not typically employed as a synthetic building block. Ifosfamide is the target compound itself rather than a reagent/intermediate in general organic synthesis.
When encountered in synthesis (literature context):
Retrosynthetic note (general):
Practical takeaway:
Not applicable. This product is a small-molecule compound, not a biological affinity reagent (e.g., antibody, inhibitor with a single defined protein target in an in vitro binding sense). Ifosfamide exerts broad biochemical reactivity after metabolic activation, alkylating nucleophilic sites in biomacromolecules. For mechanistic details, see Biological Roles.
当社のグレード選定ガイドでは、カタログ内のすべてのバリエーションについて、純度、安定剤の状態、用途への適合性を網羅しています。
Moligand™ グレードガイドを見る → Pharmaceutical grade グレードガイドを見る →